NasdaqCM - Delayed Quote USD

Intensity Therapeutics, Inc. (INTS)

0.4752
+0.0862
+(22.16%)
At close: May 30 at 4:00:00 PM EDT
0.4352
-0.04
(-8.42%)
After hours: May 30 at 7:41:15 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Lewis H. Bender M.A., M.B.A., M.S. Founder, President, CEO & Chairman of the Board 597.01k -- 1959
Mr. Joseph Talamo CPA, M.B.A. Chief Financial Officer 416.93k -- 1969
Mr. John Wesolowski CPA, M.B.A. Principal Accounting Officer & Controller 260.9k -- 1960
Mr. James M. Ahlers Executive Vice President of Corporate Finance 75.09k -- 1964
Mr. Brian Schwartz M.D. Executive Vice President of Clinical Development -- -- --

Intensity Therapeutics, Inc.

1 Enterprise Drive
Suite 430
Shelton, CT 06484-4779
United States
203 221 7381 https://www.intensitytherapeutics.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
5

Description

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Corporate Governance

Intensity Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 20, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 24, 2025 at 12:00 AM UTC

S-1/A: Offering Registrations

April 22, 2025 at 12:00 AM UTC

S-1: Offering Registrations

March 28, 2025 at 12:00 AM UTC

DRS: Offering Registrations

March 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 7, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

December 17, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

December 13, 2024 at 12:00 AM UTC

S-1: Offering Registrations

Related Tickers